CRP and inflammatory bowel disease: However, in patients with IBD, examining the contribution of various clinical covariates at the time of stool testing to Bray-Curtis dissimilarity-based PCoA analysis, IBD subtypes and biomarkers of inflammation such as C-reactive protein had larger relative influences on the gut microbiome compared with the presence of an E. coli subtype or norovirus (Figure 3d).